These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26618255)

  • 1. Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Kitada S; Schulze PC; Jin Z; Clerkin K; Homma S; Mancini DM
    Int J Cardiol; 2016 Jan; 203():929-935. PubMed ID: 26618255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-Year Clinical Outcome in End-Stage Heart Failure: Comparison of "High Urgent" Listing for Heart Transplantation with Mechanical Circulatory Support Implantation.
    Sunavsky J; Zittermann A; Oezpeker C; Fujita B; Fuchs U; Gummert JF; Schulz U
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):647-52. PubMed ID: 26177226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database.
    Healy AH; Baird BC; Drakos SG; Stehlik J; Selzman CH
    Ann Thorac Surg; 2013 Mar; 95(3):870-5. PubMed ID: 23218024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
    Emani S; Tumin D; Foraker RE; Hayes D; Smith SA
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27862317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Destiny of candidates for heart transplantation in the Eurotransplant heart allocation system.
    Komoda T; Hetzer R; Lehmkuhl HB
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):301-6; discussion 306. PubMed ID: 18406621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Year Left Ventricular Assist Device Outcomes and Strategy After Heart Transplant Allocation Score Change.
    Agronin J; Brown M; Calvelli H; Zhao H; Rakita V; Toyoda Y; Kashem MA
    Am J Cardiol; 2024 Sep; 226():1-8. PubMed ID: 38972536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in status 2 patients listed for heart transplantation in the United States: Will understanding cause of death help justify implantation of left ventricular assist devices into less sick patients?
    Morris AA; Chen C; Laskar SR; Smith AL; Vega JD
    Int J Cardiol; 2019 Feb; 276():185-190. PubMed ID: 30482444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous-flow left ventricular assist devices associated survival awaiting heart and heart-kidney transplant.
    Weber MP; O'Malley TJ; Maynes EJ; Choi JH; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2023 Apr; 47(4):770-776. PubMed ID: 36448269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart transplantation outcomes in patients with continuous-flow left ventricular assist device-related complications.
    Quader MA; Wolfe LG; Kasirajan V
    J Heart Lung Transplant; 2015 Jan; 34(1):75-81. PubMed ID: 25150620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous flow left ventricular assist device technology has influenced wait times and affected donor allocation in cardiac transplantation.
    Taghavi S; Jayarajan SN; Komaroff E; Mangi AA
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1966-71, 1971.e1. PubMed ID: 24613158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of total artificial heart and biventricular assist device support as bridge-to-transplantation.
    Cheng A; Trivedi JR; Van Berkel VH; Massey HT; Slaughter MS
    J Card Surg; 2016 Oct; 31(10):648-653. PubMed ID: 27573150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical circulatory support pathways that maximize post-heart transplant survival.
    Karamlou T; Gelow J; Diggs BS; Tibayan FA; Mudd JM; Guyton SW; Slater MS; Song HK
    Ann Thorac Surg; 2013 Feb; 95(2):480-5; discussion 485. PubMed ID: 22921240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.